Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines. - Park,JW.; Zarnegar,R.; Kanauchi,H.; Wong,MG.; Hyun,WC.; Ginzinger,DG.; Lobo,M.; Cotter,P.; Duh,QY.; Clark,OH. (Thyroid, 2005)